Skip to main content
. 2022 Aug 22;10(3):221–226. doi: 10.4103/sjmms.sjmms_576_21

Table 3.

Relationship between mortality and patient characteristics, comorbidities, length of hospitalization, serum creatinine, sodium, potassium, and blood urea nitrogen levels

Variable Mortality
χ 2 P
Yes, n (%) No, n (%)
Age 66±15.5 59.3±16.6 3.85* 0.001
Referral
  Early 58 (22) 206 (78) 46.33 0.001
  Late 76 (55.9) 60 (44.1)
Gender
  Female 62 (36.9) 106 (63.1) 1.5 0.22
  Male 72 (31) 160 (69)
Needed for RRT 58 (46) 68 (54) 12.69 <0.001
Diabetes mellitus 99 (88.2) 160 (61.8) 7.36 0.007
Hypertension 99 (36.1) 175 (63.9) 2.7 0.1
Ischemic heart disease 52 (46) 61 (54) 11.07 0.001
Congestive heart failure 28 (36.8) 48 (63.2) 0.47 0.493
Cerebrovascular diseases 27 (47.4) 30 (52.6) 5.73 0.017
Chronic liver disease 17 (63) 10 (37) 11.28 0.001
Malignancy 29 (35.8) 52 (64.2) 0.24 0.623
Obstructive uropathy 6 (15) 34 (85) 6.82 0.009
Sepsis 63 (51.2) 60 (48.8) 25.03 0.001
CKD 37 (26.4) 103 (73.6) 4.83 0.028
Length of hospitalization (days) 22.5±21.1 14.4±15.9 3.7 <0.001
SCr level on the day of referral (µmol/L) 332±208.3 377.5±327.4 0.21 0.827
SCr level on day 7 after referral (µmol/L) 321.1±202.6 295.3±256.1 2.22 0.026
Maximum SCr level during admission (µmol/L) 437.9±211.4 456.1±391.0 1.92 0.054
Latest SCr reading before death (µmol/L) 354.5±191.1 270.5±235.6 5.53 0.001
Blood urea nitrogen (mmol/L) 27.9±15.5 21.5±15.5 4.63 0.001
Serum potassium (mmol/L) 4.3±0.9 4.3±0.8 0.02 0.891
Serum sodium (mmol/L) 138.1±12.5 136.0±6.7 1.81 0.07

RRT – Renal replacement therapy; SCr – Serum creatinine; CKD – Chronic kidney disease